JIANGSU ALPHA GROUP SHENGJI PHARMACEUTICAL (SUQIAN) CO LTD

Overview

JIANGSU ALPHA GROUP SHENGJI PHARMACEUTICAL (SUQIAN) CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering MONTELUKAST SODIUM INTERMEDIATE (MK-5).

API / Drug Master Files

JIANGSU ALPHA GROUP SHENGJI PHARMACEUTICAL (SUQIAN) CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MONTELUKAST SODIUM INTERMEDIATE (MK-5)Active2025-05-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGSU ALPHA GROUP SHENGJI PHARMACEUTICAL (SUQIAN) CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.